ID
ARNA

Integral Derivatives’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Integral Derivatives’s Portfolio ARNA Stock Details ARNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-1,071
Closed -$47K – 1309
2015
Q1 		$47K Buy
+1,071
New +$49.8K ﹤0.01% 1043

Other funds holding ARNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Integral Derivatives's ARNA Position: Q2 2015 in Review

Integral Derivatives sold out of Arena Pharmaceuticals Inc (ARNA) in Q2 2015, closing a stake of 1,071 shares — an estimated $47K sold.

Integral Derivatives first reported a position in ARNA in Q1 2015 and held it in 1 quarter. The position peaked at $47K in Q1 2015. 130 funds tracked by Wall St. Rank hold ARNA as of Q2 2015.

  • Integral Derivatives reported no remaining Arena Pharmaceuticals Inc position as of Q2 2015 after selling out during the quarter.
  • Integral Derivatives sold 1,071 Arena Pharmaceuticals Inc shares in Q2 2015, an estimated $47K.
  • Integral Derivatives first reported a position in Arena Pharmaceuticals Inc in Q1 2015 and held it in 1 quarter.
  • Integral Derivatives's Arena Pharmaceuticals Inc position peaked at $47K in Q1 2015.
  • 130 funds tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q2 2015.

Based on Integral Derivatives's 13F filing for Q2 2015, filed 15 Jul 2015.